Form4.ai tracks every SEC insider trade in real time. See every ASND insider filing with a free account — no card.
See every ASND insider filing — free account, no card.
Free accountAscendis Pharma A/S (ASND) has 4 SEC Form 4 insider filings on record in the last 90 days. That includes 1 insider purchase totalling $493K, and 1 sales totalling $62K. Most recent filing: Sept. 28, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Sep 9, 2026 SEC filing | Bodenhoff Mads SVP & PAO | Cashless exercise | $480,570 | — |
| Sep 3, 2026 SEC filing | HOLTUG LARS Director | Sold | $62,335 | — |
| Aug 18, 2026 SEC filing | BIENAIME JEAN JACQUES Director | Bought | $492,654 | -2.7% 30D |
Create a free account to see all 4 ASND filings from the last 90 days. No card needed.
Create free accountWant ASND insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.